17-9826074-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004246.3(GLP2R):c.11G>A(p.Gly4Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,459,278 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004246.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLP2R | NM_004246.3 | c.11G>A | p.Gly4Glu | missense_variant | 1/13 | ENST00000262441.10 | NP_004237.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLP2R | ENST00000262441.10 | c.11G>A | p.Gly4Glu | missense_variant | 1/13 | 1 | NM_004246.3 | ENSP00000262441.5 | ||
GLP2R | ENST00000574745.5 | c.-352+3789G>A | intron_variant | 2 | ENSP00000458242.1 | |||||
GLP2R | ENST00000458005.2 | n.11G>A | non_coding_transcript_exon_variant | 1/11 | 5 | ENSP00000404471.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000367 AC: 9AN: 245306Hom.: 1 AF XY: 0.0000452 AC XY: 6AN XY: 132852
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1459278Hom.: 1 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 725862
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.11G>A (p.G4E) alteration is located in exon 1 (coding exon 1) of the GLP2R gene. This alteration results from a G to A substitution at nucleotide position 11, causing the glycine (G) at amino acid position 4 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at